Successful desensitization with cetuximab (CET) after hypersensitivity reaction (HSR) to panitumumab (PAN) and CET in patients (pts) with metastatic colorectal cancer (mCRC)
Shah M, Hotchkiss S, Shanley J, Davies M, Ferencz T, Syrigos K, Syrigos K, Saif M. Successful desensitization with cetuximab (CET) after hypersensitivity reaction (HSR) to panitumumab (PAN) and CET in patients (pts) with metastatic colorectal cancer (mCRC). Journal Of Clinical Oncology 2008, 26: 15092-15092. DOI: 10.1200/jco.2008.26.15_suppl.15092.Peer-Reviewed Original ResearchMetastatic colorectal cancerHypersensitivity reactionsSuccessful desensitizationColorectal cancerCetuximabPatientsCancerDesensitization